Trial · NCT05089084
Results by group158
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 158
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline at Month 10 in Fasting Triglycerides (TG) | Placebo (Pooled) | -17.1 | Inter-Quartile Range -49.1 to 47.0 | percentage change | |
| Percent Change From Baseline at Month 10 in Fasting Triglycerides (TG) | ARO-APOC3 (Plozasiran) 25 mg | -80.1 | Inter-Quartile Range -89.9 to -61.0 | percentage change | |
| Percent Change From Baseline at Month 10 in Fasting Triglycerides (TG) | ARO-APOC3 (Plozasiran) 50 mg | -77.6 | Inter-Quartile Range -87.7 to -48.6 | percentage change | |
| Percent Change From Baseline in Fasting TG at Month 10 and Month 12 (Averaged) | Placebo (Pooled) | -2.6 | Inter-Quartile Range -45.0 to 33.3 | percentage change | |
| Percent Change From Baseline in Fasting TG at Month 10 and Month 12 (Averaged) | ARO-APOC3 (Plozasiran) 25 mg | -77.7 | Inter-Quartile Range -89.0 to -59.2 | percentage change | |
| Percent Change From Baseline in Fasting TG at Month 10 and Month 12 (Averaged) | ARO-APOC3 (Plozasiran) 50 mg | -71.0 | Inter-Quartile Range -86.7 to -52.6 | percentage change | |
| Percent Change From Baseline in Apolipoprotein C-III (APOC3) at Month 10 | Placebo (Pooled) | -1.25 | Inter-Quartile Range -16.59 to 26.46 | percentage change | |
| Percent Change From Baseline in Apolipoprotein C-III (APOC3) at Month 10 | ARO-APOC3 (Plozasiran) 25 mg | -92.95 | Inter-Quartile Range -97.58 to -87.86 | percentage change | |
| Percent Change From Baseline in Apolipoprotein C-III (APOC3) at Month 10 | ARO-APOC3 (Plozasiran) 50 mg | -96.20 | Inter-Quartile Range -97.71 to -89.88 | percentage change | |
| Percent Change From Baseline in Fasting APOC3 at Month 12 | Placebo (Pooled) | 7.69 | Inter-Quartile Range -33.65 to 31.28 | percentage change | |
| Percent Change From Baseline in Fasting APOC3 at Month 12 | ARO-APOC3 (Plozasiran) 25 mg | -89.30 | Inter-Quartile Range -93.84 to -80.24 | percentage change | |
| Percent Change From Baseline in Fasting APOC3 at Month 12 | ARO-APOC3 (Plozasiran) 50 mg | -87.73 | Inter-Quartile Range -93.01 to -78.70 | percentage change | |
| Percentage of Participants With Positively Adjudicated Events of Acute Pancreatitis (Randomized Period) | Placebo (Pooled) | 20.0 | percentage of participants | ||
| Percentage of Participants With Positively Adjudicated Events of Acute Pancreatitis (Randomized Period) | ARO-APOC3 (Plozasiran) Pooled | 4.0 | percentage of participants | ||
| Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Month 10 | Placebo (Pooled) | 3.67 | Standard Error 9.454 | percentage change | |
| Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Month 10 | ARO-APOC3 (Plozasiran) 25 mg | -38.69 | Standard Error 7.980 | percentage change | |
| Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Month 10 | ARO-APOC3 (Plozasiran) 50 mg | -36.12 | Standard Error 8.351 | percentage change | |
| Percent Change From Baseline in Non-HDL-C at Month 12 | Placebo (Pooled) | 6.72 | Standard Error 9.373 | percentage change | |
| Percent Change From Baseline in Non-HDL-C at Month 12 | ARO-APOC3 (Plozasiran) 25 mg | -38.16 | Standard Error 7.928 | percentage change | |
| Percent Change From Baseline in Non-HDL-C at Month 12 | ARO-APOC3 (Plozasiran) 50 mg | -25.48 | Standard Error 8.368 | percentage change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05089084/results